• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PYC

PYC THERAPEUTICS LIMITED - Announcements

6.43% ! $1.33
Market Cap $772.8M  !

PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company... PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company creating a new generation of ribonucleic acid (RNA) therapies to change the lives of patients with genetic diseases. The Company utilizes its proprietary drug delivery platform to enhance the potency of precision medicines within the rapidly growing and commercially proven RNA therapeutic class. Its drug development programs target monogenic diseases - the indications with the highest likelihood of success in clinical development. Its first-in-class drug programs include Retinitis Pigmentosa type 11, (VP-001), Polycystic Kidney Disease, (PYC-003), Autosomal Dominant Optic Atrophy (ADOA) (PYC-001) and Phelan-McDermid Syndrome (PMS) (PYC-002). The Company's VP-001 program is a lead asset for a blinding eye disease of childhood progressed through multiple patient cohorts in the ongoing single ascending dose clinical trial. ADOA is a progressive and blinding eye disease.More

Announcements



PYC Q1 Investor Call 17 February 202310/02/23 download Created with Sketch. 188.48KB
PYC PYC Corporate Presentation - February 202303/02/23 download Created with Sketch. 2.82MB
PYC VP-001 IND LodgementPRICE SENSITIVE02/02/23 download Created with Sketch. 158.05KB
PYC Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE20/01/23 download Created with Sketch. 223.22KB
PYC Notification of cessation of securities - PYC21/12/22 download Created with Sketch. 23.83KB
PYC PYC Increases Ownership of VP-001 ProgramPRICE SENSITIVE29/11/22 download Created with Sketch. 163.64KB
PYC Results of Annual General Meeting23/11/22 download Created with Sketch. 243.99KB
PYC 2022 AGM Chairman's Address and CEO Presentation23/11/22 download Created with Sketch. 1.76MB
PYC Annual General Meeting - Conference Call21/11/22 download Created with Sketch. 160.78KB
PYC Successful Toxicology Studies Pave Way for Human TrialsPRICE SENSITIVE07/11/22 download Created with Sketch. 223.45KB
PYC Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/10/22 download Created with Sketch. 446.75KB
PYC Issue of Options28/10/22 download Created with Sketch. 322.61KB
PYC Notification regarding unquoted securities - PYC28/10/22 download Created with Sketch. 27.57KB
PYC Notice of Annual General Meeting/Proxy Form14/10/22 download Created with Sketch. 832.75KB
PYC PYC Presenting on Drug Delivery Platform at OTS 2022 Meeting03/10/22 download Created with Sketch. 201.51KB
PYC Central Nervous System Drug Program Added to PYC PipelinePRICE SENSITIVE27/09/22 download Created with Sketch. 256.59KB
PYC Corporate Governance Statement and Appendix 4G23/09/22 download Created with Sketch. 670.25KB
PYC Annual Report to shareholders23/09/22 download Created with Sketch. 2.41MB
PYC Preliminary Final ReportPRICE SENSITIVE31/08/22 download Created with Sketch. 788.67KB
PYC PYC Shareholder Update18/08/22 download Created with Sketch. 603.36KB
PYC Change of Director's Interest Notice11/08/22 download Created with Sketch. 267.27KB
PYC PYC Therapeutics Investor Call - 18 August 202209/08/22 download Created with Sketch. 193.48KB
PYC Change of Director's Interest Notice04/08/22 download Created with Sketch. 267.27KB
PYC Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE27/07/22 download Created with Sketch. 231.28KB
PYC Share Trading Policy28/06/22 download Created with Sketch. 426.93KB
PYC Corporate Presentation - May 202231/05/22 download Created with Sketch. 728.83KB
PYC PYC Q2 Investor Call - 31 May 202227/05/22 download Created with Sketch. 191.43KB
PYC PK STUDY RESULTS MOVE RP11 CLOSER TO FIRST IN HUMAN TRIALS10/05/22 download Created with Sketch. 213.56KB
PYC Appendix A Terms and Conditions of Options04/05/22 download Created with Sketch. 123.22KB
PYC Notification regarding unquoted securities - PYC04/05/22 download Created with Sketch. 27.68KB
PYC Issue of Options04/05/22 download Created with Sketch. 179.56KB
PYC Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE29/04/22 download Created with Sketch. 238.74KB
PYC Completes FDA Pre-IND engagement - RP11 program23/03/22 download Created with Sketch. 190.45KB
PYC Q1 Investor Call Presentation17/03/22 download Created with Sketch. 278.21KB
PYC Quarterly Investor Call March 202208/03/22 download Created with Sketch. 161.84KB
PYC Notification regarding unquoted securities - PYC01/03/22 download Created with Sketch. 27.41KB
PYC Half Yearly Report and AccountsPRICE SENSITIVE28/02/22 download Created with Sketch. 2.31MB
PYC PYC Increases Shareholding in Vision PharmaPRICE SENSITIVE17/02/22 download Created with Sketch. 161.82KB
PYC Becoming a substantial holder02/02/22 download Created with Sketch. 310.61KB
PYC Quarterly Activities and Appendix 4C Cash Flow ReportPRICE SENSITIVE27/01/22 download Created with Sketch. 212.81KB
PYC Notification of cessation of securities - PYC07/01/22 download Created with Sketch. 21.75KB
PYC Change in substantial holding29/12/21 download Created with Sketch. 538.01KB
PYC Change of Registry Address20/12/21 download Created with Sketch. 152.9KB
PYC Notification of cessation of securities - PYC09/12/21 download Created with Sketch. 21.73KB
PYC Appendix C US Sub Plan30/11/21 download Created with Sketch. 156.65KB
PYC Appendix B Terms and Conditions of Options30/11/21 download Created with Sketch. 136.4KB
PYC Appendix A Terms and Conditions of Options30/11/21 download Created with Sketch. 136.28KB
PYC Notification regarding unquoted securities - PYC30/11/21 download Created with Sketch. 30.48KB
PYC Notification of cessation of securities - PYC29/11/21 download Created with Sketch. 21.69KB
PYC Final Director's Interest Notice25/11/21 download Created with Sketch. 287.11KB
PYC Results of 2021 Annual General Meeting18/11/21 download Created with Sketch. 159.65KB
PYC 2021 AGM Chairman's Address and CEO Presentation18/11/21 download Created with Sketch. 294.09KB
PYC Annual General Meeting - Conference Link17/11/21 download Created with Sketch. 161.93KB
PYC Successful Completion of Key Translational MilestonePRICE SENSITIVE16/11/21 download Created with Sketch. 190.99KB
PYC Trading HaltPRICE SENSITIVE15/11/21 download Created with Sketch. 186.73KB
PYC Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE28/10/21 download Created with Sketch. 287.47KB
PYC Notice of Annual General Meeting/Proxy Form19/10/21 download Created with Sketch. 1.08MB
PYC Retina Target Engagement Confirmed in Large EyePRICE SENSITIVE29/09/21 download Created with Sketch. 316.13KB
PYC Corporate Governance Statement and Appendix 4G22/09/21 download Created with Sketch. 669.27KB
PYC Annual Report to shareholders22/09/21 download Created with Sketch. 1.72MB
PYC Upcoming Poster Presentations at TIDES USA and OTS 202121/09/21 download Created with Sketch. 175.71KB
PYC Oppenheimer Fall Healthcare Life Sciences & MedTech Summit15/09/21 download Created with Sketch. 158.31KB
PYC Preliminary Final ReportPRICE SENSITIVE31/08/21 download Created with Sketch. 3.64MB
PYC August Investor Update17/08/21 download Created with Sketch. 1.51MB
PYC Ophthalmology-Focused Clinical Advisory Board17/08/21 download Created with Sketch. 174.51KB
PYC PYC Quarterly Investor Call - August 1711/08/21 download Created with Sketch. 191.28KB
PYC Participation in Upcoming U.S. Investor Conferences03/08/21 download Created with Sketch. 160.06KB
PYC Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE28/07/21 download Created with Sketch. 407.7KB
PYC Commencement of Larger Animal Studies for Lead Program14/07/21 download Created with Sketch. 160.02KB
PYC Change of Auditor01/07/21 download Created with Sketch. 145.35KB
PYC VP-002 Program - Technical Presentation29/06/21 download Created with Sketch. 864.11KB
PYC Exercise of Options15/06/21 download Created with Sketch. 281.94KB
PYC Application for quotation of securities - PYC15/06/21 download Created with Sketch. 25.34KB
PYC New U.S. Headquarters, and Residency at JLABS15/06/21 download Created with Sketch. 163.29KB
PYC Second Drug Program Progressing Towards Human TrialsPRICE SENSITIVE08/06/21 download Created with Sketch. 389.99KB
PYC Trading HaltPRICE SENSITIVE07/06/21 download Created with Sketch. 613.05KB
PYC Evercore ISI GenomeRx Emerging Therapeutic Company Day26/05/21 download Created with Sketch. 157.21KB
PYC SECOND DRUG PROGRAM - EFFICACY DATA IN PATIENT CELL MODELS18/05/21 download Created with Sketch. 289.67KB
PYC PYC Invited to Present at ARVO 2021 Annual Meeting04/05/21 download Created with Sketch. 175.83KB
PYC Set To Announce Efficacy Results For Second Drug Program03/05/21 download Created with Sketch. 193.64KB
PYC March 2021 Quarterly Report and CashflowPRICE SENSITIVE30/04/21 download Created with Sketch. 311.12KB
PYC Corporate Presentation April 202122/04/21 download Created with Sketch. 2.57MB
PYC April Investor Call Presentation15/04/21 download Created with Sketch. 7.45MB
PYC Preclinical Data - Superior PPMO Delivery to the Brain12/04/21 download Created with Sketch. 2.68MB
PYC Quarterly Investor Call - 15th April 202106/04/21 download Created with Sketch. 157.67KB
PYC Appendix 3X - Initial Director's Interest Notice30/03/21 download Created with Sketch. 302.3KB
PYC Appendix 3G - Issue of Options30/03/21 download Created with Sketch. 372.32KB
PYC PYC Appoints U.S. Biopharma Exec Jason Haddock to its Board29/03/21 download Created with Sketch. 163.74KB
PYC Director Retirement26/03/21 download Created with Sketch. 217.61KB
PYC Appendix 3G - Issue of Options25/03/21 download Created with Sketch. 394.25KB
PYC Initial Director's Interest Notice23/03/21 download Created with Sketch. 297.46KB
PYC Participation in SVB Leerink Biopharma Private Co Connect22/03/21 download Created with Sketch. 157.63KB
PYC PYC Appoints US Biotech Veteran to its Board of Directors17/03/21 download Created with Sketch. 227.18KB
PYC Lead Investigational Drug Demonstrates Key ImprovementPRICE SENSITIVE02/03/21 download Created with Sketch. 561.42KB
PYC Half Year Accounts and Appendix 4DPRICE SENSITIVE26/02/21 download Created with Sketch. 695.29KB
PYC PYC Expands US Executive Leadership Team23/02/21 download Created with Sketch. 195.56KB
PYC Progress US Clinical Stage Company and Corporate ObjectivesPRICE SENSITIVE22/02/21 download Created with Sketch. 243.93KB
PYC Change of Director's Interest Notice19/02/21 download Created with Sketch. 269.89KB
PYC PYC to Participate in RNA Discussion - CEO BIO Conference11/02/21 download Created with Sketch. 200.12KB
PYC Quarterly Activities Report and Appendix 4CPRICE SENSITIVE29/01/21 download Created with Sketch. 424.49KB
PYC Q1 Investor Call 17 February 2023
10/02/23 download Created with Sketch. 188.48KB
PYC PYC Corporate Presentation - February 2023
03/02/23 download Created with Sketch. 2.82MB
PYC VP-001 IND Lodgement
02/02/23PRICE SENSITIVE download Created with Sketch. 158.05KB
PYC Quarterly Activities/Appendix 4C Cash Flow Report
20/01/23PRICE SENSITIVE download Created with Sketch. 223.22KB
PYC Notification of cessation of securities - PYC
21/12/22 download Created with Sketch. 23.83KB
PYC PYC Increases Ownership of VP-001 Program
29/11/22PRICE SENSITIVE download Created with Sketch. 163.64KB
PYC Results of Annual General Meeting
23/11/22 download Created with Sketch. 243.99KB
PYC 2022 AGM Chairman's Address and CEO Presentation
23/11/22 download Created with Sketch. 1.76MB
PYC Annual General Meeting - Conference Call
21/11/22 download Created with Sketch. 160.78KB
PYC Successful Toxicology Studies Pave Way for Human Trials
07/11/22PRICE SENSITIVE download Created with Sketch. 223.45KB
PYC Quarterly Activities/Appendix 4C Cash Flow Report
31/10/22PRICE SENSITIVE download Created with Sketch. 446.75KB
PYC Issue of Options
28/10/22 download Created with Sketch. 322.61KB
PYC Notification regarding unquoted securities - PYC
28/10/22 download Created with Sketch. 27.57KB
PYC Notice of Annual General Meeting/Proxy Form
14/10/22 download Created with Sketch. 832.75KB
PYC PYC Presenting on Drug Delivery Platform at OTS 2022 Meeting
03/10/22 download Created with Sketch. 201.51KB
PYC Central Nervous System Drug Program Added to PYC Pipeline
27/09/22PRICE SENSITIVE download Created with Sketch. 256.59KB
PYC Corporate Governance Statement and Appendix 4G
23/09/22 download Created with Sketch. 670.25KB
PYC Annual Report to shareholders
23/09/22 download Created with Sketch. 2.41MB
PYC Preliminary Final Report
31/08/22PRICE SENSITIVE download Created with Sketch. 788.67KB
PYC PYC Shareholder Update
18/08/22 download Created with Sketch. 603.36KB
PYC Change of Director's Interest Notice
11/08/22 download Created with Sketch. 267.27KB
PYC PYC Therapeutics Investor Call - 18 August 2022
09/08/22 download Created with Sketch. 193.48KB
PYC Change of Director's Interest Notice
04/08/22 download Created with Sketch. 267.27KB
PYC Quarterly Activities/Appendix 4C Cash Flow Report
27/07/22PRICE SENSITIVE download Created with Sketch. 231.28KB
PYC Share Trading Policy
28/06/22 download Created with Sketch. 426.93KB
PYC Corporate Presentation - May 2022
31/05/22 download Created with Sketch. 728.83KB
PYC PYC Q2 Investor Call - 31 May 2022
27/05/22 download Created with Sketch. 191.43KB
PYC PK STUDY RESULTS MOVE RP11 CLOSER TO FIRST IN HUMAN TRIALS
10/05/22 download Created with Sketch. 213.56KB
PYC Appendix A Terms and Conditions of Options
04/05/22 download Created with Sketch. 123.22KB
PYC Notification regarding unquoted securities - PYC
04/05/22 download Created with Sketch. 27.68KB
PYC Issue of Options
04/05/22 download Created with Sketch. 179.56KB
PYC Quarterly Activities/Appendix 4C Cash Flow Report
29/04/22PRICE SENSITIVE download Created with Sketch. 238.74KB
PYC Completes FDA Pre-IND engagement - RP11 program
23/03/22 download Created with Sketch. 190.45KB
PYC Q1 Investor Call Presentation
17/03/22 download Created with Sketch. 278.21KB
PYC Quarterly Investor Call March 2022
08/03/22 download Created with Sketch. 161.84KB
PYC Notification regarding unquoted securities - PYC
01/03/22 download Created with Sketch. 27.41KB
PYC Half Yearly Report and Accounts
28/02/22PRICE SENSITIVE download Created with Sketch. 2.31MB
PYC PYC Increases Shareholding in Vision Pharma
17/02/22PRICE SENSITIVE download Created with Sketch. 161.82KB
PYC Becoming a substantial holder
02/02/22 download Created with Sketch. 310.61KB
PYC Quarterly Activities and Appendix 4C Cash Flow Report
27/01/22PRICE SENSITIVE download Created with Sketch. 212.81KB
PYC Notification of cessation of securities - PYC
07/01/22 download Created with Sketch. 21.75KB
PYC Change in substantial holding
29/12/21 download Created with Sketch. 538.01KB
PYC Change of Registry Address
20/12/21 download Created with Sketch. 152.9KB
PYC Notification of cessation of securities - PYC
09/12/21 download Created with Sketch. 21.73KB
PYC Appendix C US Sub Plan
30/11/21 download Created with Sketch. 156.65KB
PYC Appendix B Terms and Conditions of Options
30/11/21 download Created with Sketch. 136.4KB
PYC Appendix A Terms and Conditions of Options
30/11/21 download Created with Sketch. 136.28KB
PYC Notification regarding unquoted securities - PYC
30/11/21 download Created with Sketch. 30.48KB
PYC Notification of cessation of securities - PYC
29/11/21 download Created with Sketch. 21.69KB
PYC Final Director's Interest Notice
25/11/21 download Created with Sketch. 287.11KB
PYC Results of 2021 Annual General Meeting
18/11/21 download Created with Sketch. 159.65KB
PYC 2021 AGM Chairman's Address and CEO Presentation
18/11/21 download Created with Sketch. 294.09KB
PYC Annual General Meeting - Conference Link
17/11/21 download Created with Sketch. 161.93KB
PYC Successful Completion of Key Translational Milestone
16/11/21PRICE SENSITIVE download Created with Sketch. 190.99KB
PYC Trading Halt
15/11/21PRICE SENSITIVE download Created with Sketch. 186.73KB
PYC Quarterly Activities/Appendix 4C Cash Flow Report
28/10/21PRICE SENSITIVE download Created with Sketch. 287.47KB
PYC Notice of Annual General Meeting/Proxy Form
19/10/21 download Created with Sketch. 1.08MB
PYC Retina Target Engagement Confirmed in Large Eye
29/09/21PRICE SENSITIVE download Created with Sketch. 316.13KB
PYC Corporate Governance Statement and Appendix 4G
22/09/21 download Created with Sketch. 669.27KB
PYC Annual Report to shareholders
22/09/21 download Created with Sketch. 1.72MB
PYC Upcoming Poster Presentations at TIDES USA and OTS 2021
21/09/21 download Created with Sketch. 175.71KB
PYC Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
15/09/21 download Created with Sketch. 158.31KB
PYC Preliminary Final Report
31/08/21PRICE SENSITIVE download Created with Sketch. 3.64MB
PYC August Investor Update
17/08/21 download Created with Sketch. 1.51MB
PYC Ophthalmology-Focused Clinical Advisory Board
17/08/21 download Created with Sketch. 174.51KB
PYC PYC Quarterly Investor Call - August 17
11/08/21 download Created with Sketch. 191.28KB
PYC Participation in Upcoming U.S. Investor Conferences
03/08/21 download Created with Sketch. 160.06KB
PYC Quarterly Activities/Appendix 4C Cash Flow Report
28/07/21PRICE SENSITIVE download Created with Sketch. 407.7KB
PYC Commencement of Larger Animal Studies for Lead Program
14/07/21 download Created with Sketch. 160.02KB
PYC Change of Auditor
01/07/21 download Created with Sketch. 145.35KB
PYC VP-002 Program - Technical Presentation
29/06/21 download Created with Sketch. 864.11KB
PYC Exercise of Options
15/06/21 download Created with Sketch. 281.94KB
PYC Application for quotation of securities - PYC
15/06/21 download Created with Sketch. 25.34KB
PYC New U.S. Headquarters, and Residency at JLABS
15/06/21 download Created with Sketch. 163.29KB
PYC Second Drug Program Progressing Towards Human Trials
08/06/21PRICE SENSITIVE download Created with Sketch. 389.99KB
PYC Trading Halt
07/06/21PRICE SENSITIVE download Created with Sketch. 613.05KB
PYC Evercore ISI GenomeRx Emerging Therapeutic Company Day
26/05/21 download Created with Sketch. 157.21KB
PYC SECOND DRUG PROGRAM - EFFICACY DATA IN PATIENT CELL MODELS
18/05/21 download Created with Sketch. 289.67KB
PYC PYC Invited to Present at ARVO 2021 Annual Meeting
04/05/21 download Created with Sketch. 175.83KB
PYC Set To Announce Efficacy Results For Second Drug Program
03/05/21 download Created with Sketch. 193.64KB
PYC March 2021 Quarterly Report and Cashflow
30/04/21PRICE SENSITIVE download Created with Sketch. 311.12KB
PYC Corporate Presentation April 2021
22/04/21 download Created with Sketch. 2.57MB
PYC April Investor Call Presentation
15/04/21 download Created with Sketch. 7.45MB
PYC Preclinical Data - Superior PPMO Delivery to the Brain
12/04/21 download Created with Sketch. 2.68MB
PYC Quarterly Investor Call - 15th April 2021
06/04/21 download Created with Sketch. 157.67KB
PYC Appendix 3X - Initial Director's Interest Notice
30/03/21 download Created with Sketch. 302.3KB
PYC Appendix 3G - Issue of Options
30/03/21 download Created with Sketch. 372.32KB
PYC PYC Appoints U.S. Biopharma Exec Jason Haddock to its Board
29/03/21 download Created with Sketch. 163.74KB
PYC Director Retirement
26/03/21 download Created with Sketch. 217.61KB
PYC Appendix 3G - Issue of Options
25/03/21 download Created with Sketch. 394.25KB
PYC Initial Director's Interest Notice
23/03/21 download Created with Sketch. 297.46KB
PYC Participation in SVB Leerink Biopharma Private Co Connect
22/03/21 download Created with Sketch. 157.63KB
PYC PYC Appoints US Biotech Veteran to its Board of Directors
17/03/21 download Created with Sketch. 227.18KB
PYC Lead Investigational Drug Demonstrates Key Improvement
02/03/21PRICE SENSITIVE download Created with Sketch. 561.42KB
PYC Half Year Accounts and Appendix 4D
26/02/21PRICE SENSITIVE download Created with Sketch. 695.29KB
PYC PYC Expands US Executive Leadership Team
23/02/21 download Created with Sketch. 195.56KB
PYC Progress US Clinical Stage Company and Corporate Objectives
22/02/21PRICE SENSITIVE download Created with Sketch. 243.93KB
PYC Change of Director's Interest Notice
19/02/21 download Created with Sketch. 269.89KB
PYC PYC to Participate in RNA Discussion - CEO BIO Conference
11/02/21 download Created with Sketch. 200.12KB
PYC Quarterly Activities Report and Appendix 4C
29/01/21PRICE SENSITIVE download Created with Sketch. 424.49KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$1.33
Change
0.080(6.43%)
Mkt cap ! $772.8M
Open High Low Value Volume
$1.27 $1.35 $1.21 $763.8K 595.4K

Buyers (Bids)

No. Vol. Price($)
2 97719 $1.30
 

Sellers (Offers)

Price($) Vol. No.
$1.33 6599 1
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.